{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:54:40Z","timestamp":1792796080344,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008115","name":"School of Dentistry, University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006386","name":"Adenoid Cystic Carcinoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.critrevonc.2022.103792","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T11:35:57Z","timestamp":1660390557000},"page":"103792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor"],"prefix":"10.1016","volume":"179","author":[{"given":"Carolina","family":"Emerick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Viviane","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Agustin","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques E.","family":"N\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane H.","family":"Squarize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio M.","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103792_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amsu.2019.04.007","article-title":"Adenoid cystic carcinoma of the breast - discordant size on imaging and pathology: a case report and review of literature","volume":"43","author":"Agafonoff","year":"2019","journal-title":"Ann. Med Surg."},{"key":"10.1016\/j.critrevonc.2022.103792_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.scr.2017.04.003","article-title":"Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence","volume":"21","author":"Almeida","year":"2017","journal-title":"Stem Cell Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103792_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrc.2016.38","article-title":"Mechanisms of cancer dissemination along nerves","volume":"16","author":"Amit","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103792_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx017","article-title":"Targeting the oncogenic transcriptional regulator MYB in adenoid Cystic Carcinoma by inhibition of IGF1R\/AKT signaling","volume":"109","author":"Andersson","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103792_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-0194-3","article-title":"ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma","volume":"9","author":"Andersson","year":"2020","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib6","first-page":"159","article-title":"An update on tumors of the lacrimal gland","volume":"6","author":"Andreasen","year":"2017","journal-title":"Asia Pac. J. Ophthalmol. (Philos. )"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103792_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41379-018-0005-y","article-title":"Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles","volume":"31","author":"Andreasen","year":"2018","journal-title":"Mod. Pathol."},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103792_bib8","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/cncr.25818","article-title":"CpG island methylation profiling in human salivary gland adenoid cystic carcinoma","volume":"117","author":"Bell","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MOO.0b013e32835c05fd","article-title":"Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment","volume":"21","author":"Bell","year":"2013","journal-title":"Curr. Opin. Otolaryngol. Head. Neck Surg."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103792_bib10","first-page":"E724","article-title":"Mutational landscape of lacrimal gland carcinomas and implications for treatment","volume":"38","author":"Bell","year":"2016","journal-title":"Head. Neck"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103792_bib11","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1002\/cncr.26549","article-title":"Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands","volume":"118","author":"Bhayani","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.breast.2011.11.006","article-title":"Clinical review--breast adenoid cystic carcinoma","volume":"21","author":"Boujelbene","year":"2012","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-15-0859","article-title":"Recurrent fusions in MYB and MYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid Cystic Carcinoma","volume":"6","author":"Brayer","year":"2016","journal-title":"Cancer Disco"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103792_bib14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/modpathol.2011.86","article-title":"Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms","volume":"24","author":"Brill","year":"2011","journal-title":"Mod. Pathol."},{"issue":"34","key":"10.1016\/j.critrevonc.2022.103792_bib15","doi-asserted-by":"crossref","first-page":"30254","DOI":"10.1074\/jbc.M504703200","article-title":"Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-MYB mutants*","volume":"280","author":"Corradini","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103792_bib16","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.humpath.2014.07.013","article-title":"MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features","volume":"45","author":"D'Alfonso","year":"2014","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103792_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.18632\/oncotarget.26558","article-title":"Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland","volume":"10","author":"Doddapaneni","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2022.103792_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103352","article-title":"Impact of tumor site on the prognosis of salivary gland neoplasms: a systematic review and meta-analysis","volume":"162","author":"Dos Santos","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103792_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng.3502","article-title":"An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma","volume":"48","author":"Drier","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2022.103792_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.anndiagpath.2016.03.001","article-title":"Myoepithelial differentiation in cribriform, tubular and solid pattern of adenoid cystic carcinoma: a potential involvement in histological grading and prognosis","volume":"22","author":"Du","year":"2016","journal-title":"Ann. Diagn. Pathol."},{"issue":"18","key":"10.1016\/j.critrevonc.2022.103792_bib21","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1002\/cncr.27408","article-title":"Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 surveillance, epidemiology, and end results data","volume":"118","author":"Ellington","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103792_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archophthalmol.2011.1606","article-title":"Prognostic accuracy of the seventh edition vs sixth edition of the American Joint Committee on cancer tumor classification for adenoid cystic Carcinoma of the lacrimal gland","volume":"130","author":"El-Sawy","year":"2012","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103792_bib23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","article-title":"Proteogenomic analysis of salivary adenoid Cystic Carcinomas defines molecular subtypes and identifies therapeutic targets","volume":"27","author":"Ferrarotto","year":"2021","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pathol.2016.10.011","article-title":"The morphological spectrum of salivary gland type tumours of the breast","volume":"49","author":"Foschini","year":"2017","journal-title":"Pathology"},{"issue":"24","key":"10.1016\/j.critrevonc.2022.103792_bib25","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.18632\/oncotarget.2985","article-title":"A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets","volume":"5","author":"Gao","year":"2014","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.brachy.2020.09.017","article-title":"Surgery combined with iodine-125 interstitial brachytherapy for treatment of parotid adenoid cystic carcinoma: a single-institution experience","volume":"20","author":"Gao","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.critrevonc.2022.103792_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102959","article-title":"Major and minor salivary gland tumours","volume":"152","author":"Gatta","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103792_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2008-1058589","article-title":"Palatal Adenoid Cystic Carcinoma presenting as perineural spread to the cavernous sinus","volume":"8","author":"Ginsberg","year":"1998","journal-title":"Skull Base Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103792_bib29","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103792_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/IOP.0000000000000877","article-title":"Long-term outcomes of eye-sparing surgery for Adenoid Cystic Carcinoma of lacrimal gland","volume":"34","author":"Han","year":"2018","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"issue":"thesis6","key":"10.1016\/j.critrevonc.2022.103792_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.12271","article-title":"Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics","volume":"91","author":"Holstein","year":"2013","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103792_bib32","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1038\/s41598-022-12583-w","article-title":"Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast","volume":"12","author":"Ji","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2022.103792_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.oraloncology.2019.09.005","article-title":"MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma","volume":"98","author":"Jiang","year":"2019","journal-title":"Oral. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103792_bib34","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.ijrobp.2010.12.008","article-title":"management of adenoid cystic carcinoma of the breast: a rare cancer network study","volume":"82","author":"Khanfir","year":"2012","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/path.5006","article-title":"MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene","volume":"244","author":"Kim","year":"2018","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103792_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12253-014-9770-1","article-title":"Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings","volume":"21","author":"Kiss","year":"2015","journal-title":"Pathol. Oncol. Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103792_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review","volume":"12","author":"Laurie","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2022.103792_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103605","article-title":"Salivary gland cancer in the setting of tumor microenvironment: translational routes for therapy","volume":"171","author":"Lavareze","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103792_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/bjo.2010.192351","article-title":"Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland","volume":"95","author":"Le Tourneau","year":"2011","journal-title":"Br. J. Ophthalmol."},{"issue":"16","key":"10.1016\/j.critrevonc.2022.103792_bib40","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/cncr.26740","article-title":"A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the surveillance, epidemiology, and end results registry","volume":"118","author":"Li","year":"2012","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.critrevonc.2022.103792_bib41","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/cncr.24396","article-title":"Perineural invasion in","volume":"115","author":"Liebig","year":"2009","journal-title":"Cancer Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103792_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.20892\/j.issn.2095-3941.2020.0271","article-title":"Aberrantly expressed GFR\u03b1-1\/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases","volume":"18","author":"Liu","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nic.2008.01.001","article-title":"Perineural tumor spread","volume":"18","author":"Maroldi","year":"2008","journal-title":"Neuroimaging Clin. North Am."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.4573","article-title":"Genomic landscape of adenoid cystic carcinoma of the breast","volume":"237","author":"Martelotto","year":"2015","journal-title":"J. Pathol."},{"issue":"19","key":"10.1016\/j.critrevonc.2022.103792_bib45","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1158\/1078-0432.CCR-10-0463","article-title":"Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance","volume":"16","author":"Mitani","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.critrevonc.2022.103792_bib46","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-11-1870","article-title":"Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome","volume":"17","author":"Mitani","year":"2011","journal-title":"Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103792_bib47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1158\/1078-0432.CCR-15-2867-T","article-title":"Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid Cystic Carcinomas Lacking t(6;9) translocations","volume":"22","author":"Mitani","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103792_bib48","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/labinvest.2011.105","article-title":"Development and characterization of xenograft model systems for adenoid cystic carcinoma","volume":"91","author":"Moskaluk","year":"2011","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103792_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/1078-0432.CCR-16-1235","article-title":"Therapeutic inhibition of the MDM2-p53 interaction prevents recurrence of Adenoid Cystic Carcinomas","volume":"23","author":"N\u00f6r","year":"2017","journal-title":"Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103792_bib50","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1128\/MCB.01870-07","article-title":"Alternative RNA splicing produces multiple forms of c-MYB with unique transcriptional activities","volume":"28","author":"O'Rourke","year":"2008","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103792_bib51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/hed.21458","article-title":"chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review","volume":"33","author":"Papaspyrou","year":"2011","journal-title":"Head. Neck"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103792_bib52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/PAS.0000000000000878","article-title":"MYB labeling by immunohistochemistry is more sensitive and specific for breast adenoid Cystic Carcinoma than MYB labeling by FISH","volume":"41","author":"Poling","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"20","key":"10.1016\/j.critrevonc.2022.103792_bib53","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1158\/1078-0432.CCR-17-0969","article-title":"Radiosensitization of adenoid Cystic Carcinoma with MDM2 Inhibition","volume":"23","author":"Prabakaran","year":"2017","journal-title":"Clin. Cancer Res"},{"issue":"0","key":"10.1016\/j.critrevonc.2022.103792_bib54","first-page":"1","article-title":"Unexpected recurrence and rapid progression of lacrimal gland adenoid cystic carcinoma during pregnancy: a case report","volume":"0","author":"Rafizadeh","year":"2022","journal-title":"Orbit"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103792_bib55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrc2439","article-title":"MYB function in normal and cancer cells","volume":"8","author":"Ramsay","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103792_bib56","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1002\/lary.25356","article-title":"MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma","volume":"125","author":"Rettig","year":"2015","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103792_bib57","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","article-title":"The role of molecular testing in the differential diagnosis of salivary gland carcinomas","volume":"42","author":"Sk\u00e1lov\u00e1","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103792_bib58","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/2159-8290.CD-13-0830","article-title":"Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma","volume":"4","author":"Stoeck","year":"2014","journal-title":"Cancer Disco"},{"issue":"18","key":"10.1016\/j.critrevonc.2022.103792_bib59","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.18.01859","article-title":"Phase II study of lenvatinib in patients with progressive, recurrent or metastatic Adenoid Cystic Carcinoma","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103792_bib60","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1524-4741.2011.01117.x","article-title":"Adenoid cystic breast carcinoma: is axillary staging necessary in all cases? Results from the California Cancer Registry","volume":"17","author":"Thompson","year":"2011","journal-title":"Breast J."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103792_bib61","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41379-018-0008-8","article-title":"MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts","volume":"31","author":"Togashi","year":"2018","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103792_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-0714.2007.00631.x","article-title":"Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours","volume":"37","author":"Vargas","year":"2008","journal-title":"J. Oral. Pathol. Med"},{"key":"10.1016\/j.critrevonc.2022.103792_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103745","article-title":"MYB-NFIB fusion transcript in adenoid cystic carcinoma: current state of knowledge and future directions","volume":"176","author":"Wagner","year":"2022","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"14","key":"10.1016\/j.critrevonc.2022.103792_bib64","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1158\/1078-0432.CCR-15-1698","article-title":"Targeting MDM2 for treatment of Adenoid Cystic Carcinoma","volume":"22","author":"Warner","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2022.103792_bib65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.oraloncology.2018.10.012","article-title":"UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line","volume":"87","author":"Warner","year":"2018","journal-title":"Oral. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103792_bib66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/PAS.0b013e3182002777","article-title":"MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation","volume":"35","author":"West","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103792_bib67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ICU.0000000000000301","article-title":"Current treatment of lacrimal gland carcinoma","volume":"27","author":"Woo","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103792_bib68","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/odi.13480","article-title":"Notch activation leads to loss of myoepithelial differentiation and poor outcome in solid adenoid cystic carcinoma","volume":"26","author":"Zhang","year":"2020","journal-title":"Oral. Dis."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822002165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822002165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:44:43Z","timestamp":1760903083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822002165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":68,"alternative-id":["S1040842822002165"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103792","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103792"}}